WFA
BNTX icon

Wipfli Financial Advisors’s BioNTech BNTX Stock Holding History

Wipfli Financial Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Buy
+5
New +$764 ﹤0.01% 2380

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Wipfli Financial Advisors's BNTX Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in BioNTech (BNTX) in Q3 2022: 5 shares worth $1K. The stake represents ﹤0.01% of the portfolio and ranks #2380 among its holdings.

264 funds tracked by Wall St. Rank hold BNTX as of Q3 2022.

  • Wipfli Financial Advisors held 5 shares of BioNTech worth $1K as of Q3 2022.
  • BioNTech was a new Wipfli Financial Advisors position in Q3 2022.
  • BioNTech made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2380 holding.
  • 264 funds tracked by Wall St. Rank held BioNTech as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.